About Psoriasis and Its Types
Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes buildup of thick white, red, or silvery patches of skin. It alters the normal cell cycle of the skin. The new cells of the skin grow and move quickly to the surface of the skin to form patches known as "plaques". The plaques are commonly found on knees, elbows, scalp, hands, and feet. Psoriasis occurs mostly in adults, but can also be seen in children and adolescents. The etiology of the disease is unknown, however, it is believed to be an immune-mediated process. It is believed that the over-activity of the immune system can cause inflammation, thereby resulting in flaking of the skin.
The Global Psoriasis Therapeutics market to grow at a CAGR of 9.95 percent over the period 2014-2019.
Read more details at: http://www.bigmarketresearch.com/global-psoriasis-therapeutics-2015-2019-market
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Psoriasis Therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs including systemic and topical drugs used in the treatment of:
• Psoriasis
• Psoriatic Arthritis
The Global Psoriasis Therapeutics market is segmented based on the mechanism of action of the drugs used to treat psoriasis and psoriatic arthritis as illustrated below:
• TNF Inhibitors
• PDE4 Inhibitors
• Interleukin Blockers
• Others
The Global Psoriasis Therapeutics market is also segmented based on the type of molecule used for the treatment of psoriasis, as illustrated below:
• Biologics
• Small Molecules
On the basis of route of administration adopted for the treatment of psoriasis, the Global Psoriasis Therapeutics market is segmented as follows:
• Oral
• Parenteral
• Topical
The report also presents the vendor landscape and a corresponding detailed...